eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-IMTX-Immatics NV

Immatics NV IMTX

‎$‎10.900.53(5.11%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Immatics NV
Today
Create an eToro account to buy IMTX stock on a secure, user-friendly, multi-asset trading platform.
Buy Immatics NV
Buy Immatics NV
Immatics NV IMTX
Buy IMTX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
16.00
Based on analysts who covered IMTX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
More about Immatics NV
Immatics N.V. is a pioneer in the field of cancer therapeutics, specialising in T-cell therapy. The company operates globally, offering transformative and integrative therapeutic solutions for various forms of cancer.

Within the biotechnology sector, Immatics is a major player. The company is involved in discovering and developing T-cell-engaging cancer immunotherapies and other relevant therapeutic services. Despite being a distinct entity, collaborations with large pharmaceutical giants like Genmab have made the company noteworthy within the industry.

Follow the latest movements in the biotech sector by tracking IMTX's share price on your eToro watchlist.
VIEW MORE   

IMTX Stock Price Chart

‎89.57‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Immatics NV share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Immatics NV share price today is ‎$‎10.90, reflecting a ‎5.11‎% change over the last 24 hours and ‎15.96‎% over the past week. The current market capitalization of IMTX is ‎$‎1.32B with an average volume in the last three months of 777468.37. The stock has a P/E ratio of -15.59 and a dividend yield of 0%. With the stock’s beta sitting at 1.08
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎1.32B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎10.04 - ‎$‎10.91
52W Range
i
Shows the high and low prices of the last year.
‎$‎3.32 - ‎$‎13.72
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
777468.37
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-15.59
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎140.48M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎10.9
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-0.7
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.08
What Is Immatics NV?
Immatics N.V. is a pioneer in the field of cancer therapeutics, specialising in T-cell therapy. The company operates globally, offering transformative and integrative therapeutic solutions for various forms of cancer.

Within the biotechnology sector, Immatics is a major player. The company is involved in discovering and developing T-cell-engaging cancer immunotherapies and other relevant therapeutic services. Despite being a distinct entity, collaborations with large pharmaceutical giants like Genmab have made the company noteworthy within the industry.

Follow the latest movements in the biotech sector by tracking IMTX's share price on your eToro watchlist.
Get Started

How can I buy Immatics NV stocks?

To purchase Immatics NV:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Immatics NV (IMTX) page and place an order to buy Immatics NV.
Buy IMTX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Immatics NV
Invest in Immatics NV
Today
Create an eToro account to buy IMTX stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of IMTX is ‎$‎10.90.
The average price target for Immatics NV is ‎$‎16.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Immatics NV based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Immatics NV is ‎$‎1.32B
Based on 1 analysts offering recommendations for IMTX in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top